Back to Authors

Bülow, Götz-Ulrich von

Mayo Clinic

Walther Cancer Foundation

Citations 1

Selective activation of TACI by syndecan-2
Bischof, Daniela, Elsawa, Sherine F. , Mantchev, George T., Yoon, Juhan , Michels, Grace E., Nilson, A, Sutor, Shari L., Platt, Jeffrey L. , Ansell, Stephen M. , Bulow, Gotz von, Bram, Richard J. , Bülow, Götz-Ulrich von, Elsawa, Sherine F

Blood | December 16, 2005 | Volume: 107 | Issue: 8 | Pages: 3235-3242

10.1182/blood-2005-01-0256 Get It

AbstractB-lymphocyte homeostasis and function are regulated by complementary actions of the TNFR family members TACI, BCMA, and BAFF-R, which are expressed by mature B cells. How these receptors are differentially activated is not entirely understood, because the primary ligand BAFF binds to all three. We searched for alternative ligands for TACI using recombinant TACI-Fc fusion protein as a probe and identified syndecan-2 as a new binding partner. TACI binding appears to require heparan sulfate posttranslational modifications of syndecan-2, because free heparin or pretreatment with heparitinase blocked the interaction. Syndecan-2 bound TACI but bound neither BAFF-R nor BCMA. Transfected cells expressing syndecan-2 activated signaling through TACI, as indicated by an NFAT-specific reporter. Syndecan-1 and syndecan-4 were also able to induce TACI signaling in a similar manner. This is the first identification of ligands that selectively activate TACI without simultaneously triggering BCMA or BAFF-R. This finding may help explain the alternative outcomes of signaling from this family of receptors in B cells.